RecruitingNot applicableNCT00001975

Study of Skin Tumors in Tuberous Sclerosis

Studying Tuberous Sclerosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Joel Moss, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment: 400 enrolled
Eligibility: 18-90 years · All sexes
Timeline: 2000

Study locations (1)

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00001975 on ClinicalTrials.gov

Other trials for Tuberous Sclerosis

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT05534672
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
Katarzyna Kotulska

See all trials for Tuberous Sclerosis →

← Back to all trials